ResMed Inc. Common Stock (NYSE:RMD):
ResMed to Announce First Quarter Fiscal Year 2017 Results.
In the market the company is trading up by 1.43% since yesterday’s close of $63.59.
Additionally the company recently declared a dividend for shareholders that was paid on Thursday the 22nd of September 2016. The dividend was $0.330 per share for the quarter which comes to $1.32 on an annualized basis. This dividend amount represented a yeild of $2.09. The ex-dividend date was set for Tuesday the 16th of August 2016.
Company shares last traded at $64.50 which is slightly below the 50 day moving average of $67.22 and which is marginally over the 200 day moving average of $62.13. The 50 day moving average went down $-2.72 or -4.05% and the 200 day average moved up $2.37.
ResMed Inc. Common Stock currently has a P/E ratio of 25.90 and the market cap of the company is 9.08B. In the latest earnings report the EPS was $2.49 and is estimated to be $2.88 for the current year with 140,699,000 shares presently outstanding. Next quarter’s EPS is forecasted to be $0.73 with next year’s EPS projected to be $3.22.
Analysts have released opinions on the stock. On September 19 the company was rated “Neutral” by JP Morgan which is down from the previous “Overweight” rating. On August 23 the company was downgraded from “Hold” to “Underperform” in a statement from Jefferies.
On June 27, 2016 the stock rating was set at “Underperform” according to a Needham report a cut from the previous “Hold” rating. On April 28 the stock rating was upgraded to “Neutral” from “Neutral” with a current price target of $57.00 by analysts at Macquarie.
On April 27 the stock rating was downgraded from “” to “Neutral” and a price target of $57.00 was set in a report issued by Piper Jaffray. On January 22 the company was upgraded from “Neutral” to “Outperform” and a price target of $8.70 was set in an announcement from Credit Suisse.